Thomas C. Baddeley
Aberdeen, SCT AB245RP, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice.
Journal: International journal of molecular sciences
Published: May 16, 2023
Novel Method of Analysis for the Determination of Residual Formaldehyde by High-Performance Liquid Chromatography.
Journal: International journal of analytical chemistry
Published: May 24, 2022
HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine.
Journal: Biomedicines
Published: March 21, 2022
Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia.
Journal: Journal of Alzheimer's disease : JAD
Published: April 14, 2020
Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: October 29, 2019
N'-(1,3-Benzo-thia-zol-2-yl)benzene-sulfono-hydrazide: crystal structure, Hirshfeld surface analysis and computational chemistry.
Journal: Acta crystallographica. Section E, Crystallographic communications
Published: March 13, 2019
Cysteine-Independent Inhibition of Alzheimer's Disease-like Paired Helical Filament Assembly by Leuco-Methylthioninium (LMT).
Journal: Journal of molecular biology
Published: June 01, 2018
A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy.
Journal: Frontiers in molecular neuroscience
Published: July 18, 2017
In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development.
Journal: Frontiers in immunology
Published: July 04, 2017
Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease.
Journal: The Journal of pharmacology and experimental therapeutics
Published: October 17, 2014
1,3-Diphenyl-4,5-dihydro-1H-pyrazol-5-one.
Journal: Acta crystallographica. Section E, Structure reports online
Published: March 04, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026